The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
26372652 |
21 |
Pentafluorosulfanyl-containing flufenamic acid analogs: Syntheses, properties and biological activities. |
Rwth Aachen University |
25182963 |
40 |
Synthesis of non-prenyl analogues of baccharin as selective and potent inhibitors for aldo-keto reductase 1C3. |
Gifu Pharmaceutical University |
24411201 |
150 |
Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-ß-hydroxysteroid dehydrogenase (AKR1C3). |
University Of Auckland |
23845281 |
25 |
Discovery of 2-methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol: a novel, potent and selective type 5 17ß-hydroxysteroid dehydrogenase inhibitor. |
Astellas Pharma |
23454516 |
92 |
Synthesis and structure-activity relationships for 1-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-ones as novel non-carboxylate inhibitors of the aldo-keto reductase enzyme AKR1C3. |
University Of Auckland |
23353746 |
46 |
2,3-diarylpropenoic acids as selective non-steroidal inhibitors of type-5 17ß-hydroxysteroid dehydrogenase (AKR1C3). |
University Of Ljubljana |
23432095 |
160 |
Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17ß-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer. |
Vanderbilt University School Of Medicine |
22881866 |
57 |
Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library. |
University Of Ljubljana |
22877157 |
356 |
3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: highly potent and selective inhibitors of the type 5 17-ß-hydroxysteroid dehydrogenase AKR1C3. |
University Of Auckland |
22897946 |
34 |
N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3. |
University Of Ljubljana |
22263837 |
262 |
Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17ß-hydroxysteroid dehydrogenase) based on N-phenyl-aminobenzoates and their structure-activity relationships. |
University Of Pennsylvania |
22506594 |
20 |
Selective inhibition of human type-5 17ß-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis. |
Gifu Pharmaceutical University |
22507964 |
17 |
Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer. |
Perelman School Of Medicine University Of Pennsylvania |
21277203 |
24 |
Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17ß-hydroxysteroid dehydrogenase (AKR1C3). |
University Of Pennsylvania |
20850205 |
27 |
Structure-based optimization and biological evaluation of human 20a-hydroxysteroid dehydrogenase (AKR1C1) salicylic acid-based inhibitors. |
Monash University (Parkville Campus) |
19397269 |
16 |
Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1). |
Monash University (Parkville Campus) |
28976752 |
51 |
Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells. |
Gifu Pharmaceutical University |
6248635 |
48 |
Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites. |
Stanford University |